Related Experiment Video
Updated: Feb 7, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Pathogenesis and Management of Vascular Calcification in Patients with End-Stage Renal Disease
Insights
Vascular calcification is prevalent in end-stage renal disease (ESRD) patients due to abnormal bone metabolism and impaired kidney function. Understanding its pathogenesis is key to developing new treatments to improve cardiovascular outcomes.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Pathology
Background:
- Vascular calcification is a common complication in end-stage renal disease (ESRD) patients.
- ESRD patients face traditional and nontraditional cardiovascular risk factors contributing to vascular calcification.
- The transformation of vascular smooth muscle cells into osteoblast-like cells is a critical factor in calcification pathogenesis.
Purpose of the Study:
- To review the pathogenesis of vascular calcification in ESRD patients.
- To summarize current management strategies for vascular calcification in ESRD.
- To highlight the need for novel therapeutic approaches targeting the mechanisms of calcification.
Main Methods:
- Literature review of studies on vascular calcification in ESRD.
- Analysis of the role of calcium, phosphate, parathyroid hormone, and vitamin D metabolism.
- Examination of cellular mechanisms, including smooth muscle cell transformation.
Main Results:
- Vascular calcification in ESRD is linked to abnormal bone metabolism and impaired renal excretion of calcium and phosphate.
- This calcification leads to increased arterial stiffness, left ventricular hypertrophy, and reduced coronary perfusion.
- Consequences include myocardial ischemia, and elevated cardiovascular morbidity and mortality.
Conclusions:
- Current treatments focus on managing mineral and bone disorder in ESRD.
- A deeper understanding of calcification mechanisms is essential for developing new therapies.
- Novel treatments could improve cardiovascular outcomes for ESRD patients suffering from vascular calcification.
Abstract:
Vascular calcification is common in patients with end-stage renal disease (ESRD). In addition to traditional cardiovascular risk factors, ESRD patients also have a number of nontraditional cardiovascular risk factors that may play an important role in the pathogenesis of vascular calcification. The transformation of vascular smooth muscle cells into osteoblast-like cells may be a key element in the pathogenesis of vascular calcification in the presence of calcium and phosphate deposition due to abnormal bone metabolism and impaired renal excretion. Vascular calcification causes increased arterial stiffness, left ventricular hypertrophy, decreased coronary artery perfusion, myocardial ischemia, and increased cardiovascular morbidity and mortality. Although current treatment strategies focus on correcting abnormal calcium, phosphate, parathyroid hormone, or vitamin D levels in ESRD patients, a better understanding of the mechanisms of abnormal tissue calcification may lead to the development of new therapeutic agents that are capable of reducing vascular calcification and improving the cardiovascular outcome of ESRD patients. This review summarizes the pathogenesis and management of vascular calcification in ESRD patients.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Rheumatic Heart Disease III: Medical Management
Peripheral Artery Disease V: Postoperative Nursing Management

